Peritoneal ultrafiltration and refractory congestive heart failure

摘要: This prospective nonrandomized study enrolled 16 patients with congestive heart failure [NYHA (New York Heart Association) III and IV] refractory to a maximal well-tolerated drug therapy. The aims were evaluate if peritoneal ultrafiltration (PUF) could improve clinical conditions determine morbidity secondary resistant (RCHF) PUF. There (12 male, 4 female) mean age of 65.4 years (56-81 years) follow-up 15.6 months (4-33 months). Thirteen had RCHF without end-stage renal disease. Patients classified as NYHA class IV (n = 11) or 5). One anuric patient been on previous hemodialysis switched APD. PUF was obtained 2-L hypertonic dialysis solution, once day 7) every 2 days 4). Clinical improvement for all the patients. Weight decreased from 72.2 66.7 kg weekly 3.74 L (2.2-6.5 L). Sodium removal 79 mmol/day (urinary 43%, transport 57%). During period, received cardiac transplant since 7 died due reasons. Mean hospitalization time 4.4 1.20 per before after PUF, respectively. Hospitalization in keeping either (36%), complications (16%), miscellaneous causes (48%). Our experience showed that functional better quality life achieved these low rate hospitalization.